Bank of Montreal
FSTX

Bank of Montreal’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Bank of Montreal’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5
Closed – – 5072
2019
Q2 		$0 Buy
+5
New +$134 ﹤0.01% 5145
2019
Q1 		– Sell
-49
Closed -$2K – 4888
2018
Q4 		$2K Buy
49
+24
+96% +$1.08K ﹤0.01% 4453
2018
Q3 		$1K Buy
25
+5
+25% +$250 ﹤0.01% 4637
2018
Q2 		$1K Buy
+20
New +$1.11K ﹤0.01% 4628

Other funds holding FSTX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Bank of Montreal's FSTX Position: Q3 2019 in Review

Bank of Montreal sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q3 2019, closing a stake of 5 shares.

Bank of Montreal first reported a position in FSTX in Q2 2018 and held it in 4 quarters. The position peaked at $2K in Q4 2018. 40 funds tracked by Wall St. Rank hold FSTX as of Q3 2019.

  • Bank of Montreal reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 5 F-star Therapeutics, Inc. Common Stock shares in Q3 2019.
  • Bank of Montreal first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • Bank of Montreal's F-star Therapeutics, Inc. Common Stock position peaked at $2K in Q4 2018.
  • 40 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.